Synergistic Anticancer Activity of Fucoidan from Lessonia trabeculata Combined with Chemotherapeutic Agents in 4T1 Breast Spheroids
Marine Drugs · 26.11.2025 · 23 (12) · 451
DOI: 10.3390/md23120451 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 26.11.2025. Verfasst von Rosa María Condori Macuri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Group Immunomodulators and Antitumor of Natural and Synthetic Origen, Immunology Laboratory, Universidad Nacional Mayor de San Marcos, Lima …. Hauptthemen laut MEDLINE: Polysaccharides, Antineoplastic Agents, Triple Negative Breast Neoplasms, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National University of San Marcos, Universidad Nacional Mayor de San Marcos.
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) is known for being aggressive and potentially resistant to chemotherapy. This means that new ways to improve cancer treatments are a priority. So, the anticancer effect of binary combinations of fucoidan (FuLt) and the chemotherapeutic agents doxorubicin, paclitaxel, and 5-fluorouracil was evaluated. The Chou-Talalay combination index method was used to do this. This method allows the assessment of interactions between products by determining synergism, additive effect and antagonism with combination index 1, respectively. Synergistic indices (SIs) were selected and applied to 4T1 homotypic spheroids. Oxidative stress caused by SIs was determined after 72 h by measuring the production of ROS and NO in both homotypic and heterotypic spheroids. Three SIs with an inhibitory effect of at least ≥ 0.50 and a dose reduction index > 1 were selected. Considering the experimental and simulated SI, twelve, nineteen, and seven SIs were found for FuLt with doxorubicin, paclitaxel, and 5-fluorouracil, respectively. The highest levels of ROS and NO occurred at 12 and 72 h, respectively, in homotypic and heterotypic spheroids, indicating an immunomodulatory effect in heterotypic spheroids. These results suggest that the synergistic combination of FuLt with chemotherapeutic agents improves drug efficacy and modulates redox dynamics in 4T1 spheroids. Furthermore, FuLt alone exhibits cytotoxic properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Group Immunomodulators and Antitumor of Natural and Synthetic Origen, Immunology Laboratory, Universidad Nacional Mayor de San Marcos, Lima 11-0058, Peru.
ORCID-Profile: Rosa María Condori Macuri, Libertad Alzamora-Gonzales, Erasmo Honorio Colona-Vallejos, Raisa Teresa Cruz Riquelme, Laura Inés Pecho Chávez, Jherson Oscar Cisneros Gutierrez, Victor Alonso Montejo Anlas
Förderung
- National University of San Marcos
- Universidad Nacional Mayor de San Marcos
Zitieren
APA
Condori Macuri, R. M., Alzamora-Gonzales, L., Colona-Vallejos, E. H., Cruz Riquelme, R. T., Pecho Chávez, L. I., Cisneros Gutierrez, J. O., & Montejo Anlas, V. A. (2025). Synergistic Anticancer Activity of Fucoidan from Lessonia trabeculata Combined with Chemotherapeutic Agents in 4T1 Breast Spheroids. Marine Drugs, 23(12), 451. https://doi.org/10.3390/md23120451
Vancouver
Condori Macuri RM, Alzamora-Gonzales L, Colona-Vallejos EH, Cruz Riquelme RT, Pecho Chávez LI, Cisneros Gutierrez JO, et al. Synergistic Anticancer Activity of Fucoidan from Lessonia trabeculata Combined with Chemotherapeutic Agents in 4T1 Breast Spheroids. Marine Drugs. 2025;23(12):451. doi:10.3390/md23120451
BibTeX
@article{CondoriMacuri2025,
author = {Condori Macuri, Rosa María and Alzamora-Gonzales, Libertad and Colona-Vallejos, Erasmo Honorio and Cruz Riquelme, Raisa Teresa and Pecho Chávez, Laura Inés and Cisneros Gutierrez, Jherson Oscar and Montejo Anlas, Victor Alonso},
title = {Synergistic Anticancer Activity of Fucoidan from Lessonia trabeculata Combined with Chemotherapeutic Agents in 4T1 Breast Spheroids},
journal = {Marine Drugs},
year = {2025},
volume = {23},
number = {12},
pages = {451},
doi = {10.3390/md23120451}
}
EUVIMED